Lord's Mark Industries Ltd has inaugurated a new in-vitro diagnostics (IVD) manufacturing facility in India, completed two months ahead of the original schedule. The facility is set to bolster India's diagnostic infrastructure by producing a wide range of test kits and reagents locally.
Strategic Expansion in Diagnostics
The new manufacturing unit, located in [city/region if known, otherwise unspecified], aims to reduce dependence on imported diagnostic products. According to a company spokesperson, the early completion reflects the company's commitment to advancing healthcare accessibility and supporting the government's 'Make in India' initiative.
The facility will produce essential IVD products, including test kits for infectious diseases, metabolic disorders, and other chronic conditions. This expansion is expected to enhance the supply chain resilience for critical diagnostic tools within the country.
Impact on Healthcare Infrastructure
With this launch, Lord's Mark Industries Ltd positions itself as a key player in India's growing medical device sector. The company stated that the facility will create hundreds of direct and indirect jobs, contributing to local economic development. Additionally, the increased domestic production capacity is anticipated to lower costs for healthcare providers and patients.
"This facility is a testament to our dedication to strengthening India's healthcare backbone," said a company representative. "By manufacturing high-quality IVD products locally, we aim to ensure timely and affordable diagnostics for all."
Alignment with National Goals
The early inauguration aligns with the Indian government's efforts to promote self-reliance in medical device manufacturing. The Production Linked Incentive (PLI) scheme for medical devices has encouraged companies like Lord's Mark to invest in domestic production. The new facility is expected to comply with stringent quality standards, including ISO certifications and regulatory approvals from the Central Drugs Standard Control Organization (CDSCO).
Industry experts note that such investments are crucial for India to achieve its goal of becoming a global hub for medical device manufacturing. The country currently imports about 80% of its medical devices, and initiatives like this help reduce that dependency.
The company did not disclose the exact investment amount but confirmed that the facility is equipped with advanced automation and quality control systems to ensure consistent product reliability.
